Cotinga Pharmaceuticals Inc.

COTQFOTCHealthcare

$0.00

+$0.00(+0.00%)

Market Cap$2199

P/E Ratio—

52W High$0.0001

52W Low$0.0001

Avg Volume4K

Open$0.00

Beta-9.29

Overview

Cotinga Pharmaceuticals Inc. (COTQF) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

COTQF · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2020Report Date: Apr 1, 2020

EPS Actual

-$0.02

Revenue

—

Fiscal Period

Q2 FY2020

FY ends December

Report Date

Apr 1, 2020

After Market Close

✓ 3-Quarter EPS Beat Streak

COTQF reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
— Q2 FY2020	Apr 1, 2020	—	-$0.02	—	—	—	—
— Q4 FY2019	Dec 27, 2019	—	-$0.02	—	—	—	—
— Q4 FY2019	Oct 30, 2019	—	-$0.02	—	—	—	—
— Q2 FY2019	Apr 1, 2019	—	-$0.01	—	—	—	—
— Q4 FY2018	Dec 31, 2018	—	-$0.02	—	—	—	—
— Q4 FY2018	Oct 1, 2018	—	-$0.03	—	—	—	—
— Q3 FY2018	Aug 28, 2018	—	-$0.08	—	—	—	—
▲ Q2 FY2018	Apr 3, 2018	-$0.11	-$0.06	+45.5%	—	—	—

Q2 FY2020

Apr 1, 2020

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2019

Dec 27, 2019

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2019

Oct 30, 2019

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2019

Apr 1, 2019

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2018

Dec 31, 2018

EPS Actual

-$0.02

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2018

Oct 1, 2018

EPS Actual

-$0.03

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q3 FY2018

Aug 28, 2018

EPS Actual

-$0.08

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2018

Apr 3, 2018Beat

EPS Actual

-$0.06

EPS Est.

-$0.11

EPS Surpr.

+45.5%

Revenue

—

No analyst estimates available for COTQF.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2020	Apr 1, 2020	—	$0.01	$0.00	-37.50%
— Q4 FY2019	Dec 27, 2019	—	$0.01	$0.01	+0.00%
— Q4 FY2019	Oct 30, 2019	—	$0.01	$0.01	-18.32%
— Q2 FY2019	Apr 1, 2019	—	$0.01	$0.01	+0.00%
— Q4 FY2018	Dec 31, 2018	—	$0.00	$0.00	-8.62%
— Q4 FY2018	Oct 1, 2018	—	$0.01	$0.01	+0.00%
— Q3 FY2018	Aug 28, 2018	—	$0.03	$0.03	-2.36%
▲ Q2 FY2018	Apr 3, 2018	+45.5%	$0.03	$0.03	+0.00%

Q2 FY2020-37.50%

Report Date

Apr 1, 2020

EPS Beat/Miss

—

Price Before

$0.01

Price After

$0.00

Q4 FY2019+0.00%

Report Date

Dec 27, 2019

EPS Beat/Miss

—

Price Before

$0.01

Price After

$0.01

Q4 FY2019-18.32%

Report Date

Oct 30, 2019

EPS Beat/Miss

—

Price Before

$0.01

Price After

$0.01

Q2 FY2019+0.00%

Report Date

Apr 1, 2019

EPS Beat/Miss

—

Price Before

$0.01

Price After

$0.01

Q4 FY2018-8.62%

Report Date

Dec 31, 2018

EPS Beat/Miss

—

Price Before

$0.00

Price After

$0.00

Q4 FY2018+0.00%

Report Date

Oct 1, 2018

EPS Beat/Miss

—

Price Before

$0.01

Price After

$0.01

Q3 FY2018-2.36%

Report Date

Aug 28, 2018

EPS Beat/Miss

—

Price Before

$0.03

Price After

$0.03

Q2 FY2018+0.00%

Report Date

Apr 3, 2018

EPS Beat/Miss

+45.5%

Price Before

$0.03

Price After

$0.03

Avg Beat Reaction+0.00%

Beat Rate1 / 8 quarters

Largest Move-37.50% (Q2 FY2020)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Cotinga Pharmaceuticals Inc. (COTQF) most recently reported earnings on April 1, 2020 for Q2 FY2020, posting EPS of $-0.02 (in line with the analyst consensus of —). COTQF has beaten EPS estimates for 3 consecutive quarters. The next COTQF earnings date is expected around September 1, 2026.

Each quarter, investors track COTQF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. COTQF revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

COTQF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

COTQF earnings · 4 questions

Cotinga Pharmaceuticals Inc.'s next earnings report is expected around September 1, 2026. COTQF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; COTQF historically reports after market close (AMC).

COTQF earnings datewhen is COTQF earningsCOTQF next earnings datewhen does COTQF report earningsCOTQF earnings calendar

▸ Source: FMP · Cotinga Pharmaceuticals Inc. SEC filings · US GAAP · Cotinga Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026